To Undertake The First Fetal Brain Surgery, Two Boston Hospitals Work Together.

Jun, 2023 - by CMI

At 34 weeks gestation, a brain vein abnormality was effectively treated by doctors.

A life-saving brain procedure was carried out on a fetus while it was still in the womb at two different institutions in the city of Boston. According to WBZ, a group of neurosurgeons from Boston Children's Hospital and Brigham and Women's Hospital carried out the cerebrovascular surgery on March 15.

On Thursday, the Brigham and Women's Medical Center made the announcement that the treatment had been successful in treating the baby's aggressive Galen congenital vascular malfunction before birth, so avoiding a deadly developmental syndrome from occurring. Boston Children's Hospital says a vein of Galen deformity can cause congestive heart failure, pulmonary hypertension, brain tissue loss, and hydrocephalus. The uterine operation took place after 34 weeks and 2 days of gestation. Denver, a beautiful baby girl, was born on the third day without any problems. The US had its first fetal brain surgery. The FDA oversaw the clinical trial.

The Cerebrovascular Surgery & Interventions Center at Boston Children's Hospital's co-director, Dr. Darren B. Orbach, M.D., Ph.D., expressed the delight of the medical team at the absence of the post-birth drop. "We are pleased to report that the baby is doing remarkably well at six weeks. He or she has returned to their original home, is eating normally, is gaining weight, and no longer requires any medication. According to Orbach, there is no evidence to support the idea that the brain will suffer any negative effects. Orbach claims that the successful therapy opens the door for a more proactive approach to the treatment of vein of Galen malformation, in which doctors fix the issue prior to delivery in order to prevent heart failure, as opposed to trying to reverse it after heart failure has already occurred in the patient.

It was said by him that carrying out such an action "may significantly lower the risk of long-term brain damage, disability, or death among these infants."